Copy to clipboard 
OrtoWay-US received a new U.S. patent for its OrtoWell Distractor system. The patent, US 12,023017 B1, “Apparatus, Methods and Systems for Spine Surgery,” covers the application of the company’s hydraulically powered distractor for use in corpectomy procedures.
The OrtoWell Distractor System, originally invented in Sweden and now manufactured in Tüttlingen, Germany (with U.S. production planned), opens new possibilities for spinal surgeons seeking to separate vertebrae for disc implant insertion. Traditional handheld wedge distractors, clamps and retractors may struggle to maintain structural integrity during longer operations.
The novel OrtoWell device leverages hydraulic power, enabling spinal surgeons to carry out safer, smoother, gentler and more controlled separation of vertebral bodies. This is achieved through a controlled, measured and reproducible solution for opening the space between vertebra, making it easier to remove a disc – without excessive force.
To date, the distractor system has been utilized in more than 50 surgeries worldwide. It includes several permanent parts that must be autoclaved on site (distractor unit, spanner tools, retractors, frame, tools, tray) as well as refurbishable parts (tube unit, gauge, hooks, bone screws), which are returned to us for inspection, cleaning and sterilization. The revenue model is based on repeatable use of refurbished parts.
To meet the demands of German and U.S. spinal clinics and hospitals, OrtoWay-US Inc. recently established a subsidiary, OrtoWay GmbH, in southern Germany near Tüttlingen. The company also operates out of Horsham, PA, USA, near Philadelphia, and plans to initiate manufacturing operations in Pennsylvania.
“We are thrilled to receive this newly issued U.S. patent,” says Stan Mikulowski, CEO of OrtoWay-US Inc. “While we have already obtained FDA approval, securing our intellectual property is a crucial step for future investors and our continued commercial success.”
Source: OrtoWay-US Inc.
OrtoWay-US received a new U.S. patent for its OrtoWell Distractor system. The patent, US 12,023017 B1, “Apparatus, Methods and Systems for Spine Surgery,” covers the application of the company’s hydraulically powered distractor for use in corpectomy procedures.
The OrtoWell Distractor System, originally invented in Sweden and now manufactured...
OrtoWay-US received a new U.S. patent for its OrtoWell Distractor system. The patent, US 12,023017 B1, “Apparatus, Methods and Systems for Spine Surgery,” covers the application of the company’s hydraulically powered distractor for use in corpectomy procedures.
The OrtoWell Distractor System, originally invented in Sweden and now manufactured in Tüttlingen, Germany (with U.S. production planned), opens new possibilities for spinal surgeons seeking to separate vertebrae for disc implant insertion. Traditional handheld wedge distractors, clamps and retractors may struggle to maintain structural integrity during longer operations.
The novel OrtoWell device leverages hydraulic power, enabling spinal surgeons to carry out safer, smoother, gentler and more controlled separation of vertebral bodies. This is achieved through a controlled, measured and reproducible solution for opening the space between vertebra, making it easier to remove a disc – without excessive force.
To date, the distractor system has been utilized in more than 50 surgeries worldwide. It includes several permanent parts that must be autoclaved on site (distractor unit, spanner tools, retractors, frame, tools, tray) as well as refurbishable parts (tube unit, gauge, hooks, bone screws), which are returned to us for inspection, cleaning and sterilization. The revenue model is based on repeatable use of refurbished parts.
To meet the demands of German and U.S. spinal clinics and hospitals, OrtoWay-US Inc. recently established a subsidiary, OrtoWay GmbH, in southern Germany near Tüttlingen. The company also operates out of Horsham, PA, USA, near Philadelphia, and plans to initiate manufacturing operations in Pennsylvania.
“We are thrilled to receive this newly issued U.S. patent,” says Stan Mikulowski, CEO of OrtoWay-US Inc. “While we have already obtained FDA approval, securing our intellectual property is a crucial step for future investors and our continued commercial success.”
Source: OrtoWay-US Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
